ISPOR SPONSORING SESSION AT DIA 2016 THIS JUNE

Published Apr 5, 2016
ANNOUNCEMENT

SOCIETY’S PRESIDENT-ELECT, LOU GARRISON, LEADING WORKSHOP

Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is attending and contributing to the Drug Information Association (DIA) Annual Meeting being held June 26-30, 2016 in Philadelphia, PA, USA.  ISPOR will be sponsoring a preconference workshop on Sunday, June 26 at DIA 2016. ISPOR President-Elect Lou Garrison, PhD will be one of the instructors for the half-day session entitled, The Evolving Role of Payers in Drug Development: Pricing, Pharmacoeconomics, and Health Technology Assessment. ISPOR is offering this preconference tutorial at this event to provide expanded access to educational resources as part of its mission to promote health economics and outcomes research (HEOR) excellence to improve decision making for health globally. For additional information, please contact Betsy Lane, director, chief marketing and communications officer at BLane@ispor.org or 609-586-4981 x112.

###

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×